vs

Side-by-side financial comparison of Industrial Logistics Properties Trust (ILPT) and NEOGENOMICS INC (NEO). Click either name above to swap in a different company.

NEOGENOMICS INC is the larger business by last-quarter revenue ($186.7M vs $113.9M, roughly 1.6× Industrial Logistics Properties Trust). Industrial Logistics Properties Trust runs the higher net margin — -1.6% vs -57.9%, a 56.3% gap on every dollar of revenue. On growth, NEOGENOMICS INC posted the faster year-over-year revenue change (11.1% vs 3.1%). Over the past eight quarters, NEOGENOMICS INC's revenue compounded faster (6.5% CAGR vs 0.7%).

Industrial Logistics Properties Trust is a real estate investment trust that owns and operates a portfolio of industrial and logistics real estate assets primarily across the United States. Its holdings include distribution centers, warehouses, and last-mile delivery properties, serving e-commerce, retail, manufacturing and supply chain operators to meet their storage and logistics operation needs.

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization (FISH), flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics.

ILPT vs NEO — Head-to-Head

Bigger by revenue
NEO
NEO
1.6× larger
NEO
$186.7M
$113.9M
ILPT
Growing faster (revenue YoY)
NEO
NEO
+8.0% gap
NEO
11.1%
3.1%
ILPT
Higher net margin
ILPT
ILPT
56.3% more per $
ILPT
-1.6%
-57.9%
NEO
Faster 2-yr revenue CAGR
NEO
NEO
Annualised
NEO
6.5%
0.7%
ILPT

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
ILPT
ILPT
NEO
NEO
Revenue
$113.9M
$186.7M
Net Profit
$-1.8M
$-108.0M
Gross Margin
43.3%
Operating Margin
-22.1%
46.9%
Net Margin
-1.6%
-57.9%
Revenue YoY
3.1%
11.1%
Net Profit YoY
92.6%
42.0%
EPS (diluted)
$-0.02
$-0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ILPT
ILPT
NEO
NEO
Q1 26
$186.7M
Q4 25
$113.9M
$190.2M
Q3 25
$110.9M
$187.8M
Q2 25
$112.1M
$181.3M
Q1 25
$111.9M
$168.0M
Q4 24
$110.5M
$172.0M
Q3 24
$108.9M
$167.8M
Q2 24
$110.6M
$164.5M
Net Profit
ILPT
ILPT
NEO
NEO
Q1 26
$-108.0M
Q4 25
$-1.8M
Q3 25
$-21.6M
$-27.1M
Q2 25
$-21.3M
$-45.1M
Q1 25
$-21.5M
$-25.9M
Q4 24
$-24.1M
Q3 24
$-25.0M
$-17.7M
Q2 24
$-23.2M
$-18.6M
Gross Margin
ILPT
ILPT
NEO
NEO
Q1 26
43.3%
Q4 25
43.8%
Q3 25
42.8%
Q2 25
42.6%
Q1 25
43.6%
Q4 24
44.9%
Q3 24
44.6%
Q2 24
44.1%
Operating Margin
ILPT
ILPT
NEO
NEO
Q1 26
46.9%
Q4 25
-22.1%
-7.1%
Q3 25
-29.4%
-14.4%
Q2 25
-30.8%
-26.3%
Q1 25
-26.9%
-16.6%
Q4 24
-31.1%
-10.7%
Q3 24
-33.5%
-12.6%
Q2 24
-32.4%
-13.3%
Net Margin
ILPT
ILPT
NEO
NEO
Q1 26
-57.9%
Q4 25
-1.6%
Q3 25
-19.4%
-14.4%
Q2 25
-19.0%
-24.9%
Q1 25
-19.2%
-15.4%
Q4 24
-21.8%
Q3 24
-22.9%
-10.5%
Q2 24
-20.9%
-11.3%
EPS (diluted)
ILPT
ILPT
NEO
NEO
Q1 26
$-0.13
Q4 25
$-0.02
Q3 25
$-0.33
Q2 25
$-0.32
Q1 25
$-0.33
Q4 24
$-0.37
Q3 24
$-0.38
Q2 24
$-0.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ILPT
ILPT
NEO
NEO
Cash + ST InvestmentsLiquidity on hand
$94.8M
$146.1M
Total DebtLower is stronger
$4.2B
Stockholders' EquityBook value
$489.7M
$828.8M
Total Assets
$5.2B
$1.3B
Debt / EquityLower = less leverage
8.56×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ILPT
ILPT
NEO
NEO
Q1 26
$146.1M
Q4 25
$94.8M
$159.6M
Q3 25
$83.2M
$164.1M
Q2 25
$58.6M
$154.7M
Q1 25
$108.0M
$346.2M
Q4 24
$131.7M
$367.0M
Q3 24
$153.9M
$362.0M
Q2 24
$146.2M
$355.1M
Total Debt
ILPT
ILPT
NEO
NEO
Q1 26
Q4 25
$4.2B
$341.9M
Q3 25
$4.2B
Q2 25
$4.2B
Q1 25
$4.3B
Q4 24
$4.3B
$541.1M
Q3 24
$4.3B
Q2 24
$4.3B
Stockholders' Equity
ILPT
ILPT
NEO
NEO
Q1 26
$828.8M
Q4 25
$489.7M
$836.6M
Q3 25
$494.1M
$838.3M
Q2 25
$519.1M
$854.0M
Q1 25
$539.5M
$888.3M
Q4 24
$562.0M
$902.3M
Q3 24
$585.9M
$908.2M
Q2 24
$618.3M
$915.9M
Total Assets
ILPT
ILPT
NEO
NEO
Q1 26
$1.3B
Q4 25
$5.2B
$1.4B
Q3 25
$5.2B
$1.4B
Q2 25
$5.2B
$1.4B
Q1 25
$5.4B
$1.6B
Q4 24
$5.4B
$1.6B
Q3 24
$5.5B
$1.6B
Q2 24
$5.5B
$1.6B
Debt / Equity
ILPT
ILPT
NEO
NEO
Q1 26
Q4 25
8.56×
0.41×
Q3 25
8.49×
Q2 25
8.09×
Q1 25
7.96×
Q4 24
7.65×
0.60×
Q3 24
7.35×
Q2 24
6.96×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ILPT
ILPT
NEO
NEO
Operating Cash FlowLast quarter
$60.7M
$-8.1M
Free Cash FlowOCF − Capex
$42.0M
FCF MarginFCF / Revenue
36.9%
Capex IntensityCapex / Revenue
16.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$79.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ILPT
ILPT
NEO
NEO
Q1 26
$-8.1M
Q4 25
$60.7M
$1.3M
Q3 25
$22.7M
$8.9M
Q2 25
$18.4M
$20.3M
Q1 25
$11.4M
$-25.3M
Q4 24
$2.0M
$9.8M
Q3 24
$-3.4M
$9.2M
Q2 24
$10.8M
$13.9M
Free Cash Flow
ILPT
ILPT
NEO
NEO
Q1 26
Q4 25
$42.0M
$-6.5M
Q3 25
$17.6M
$570.0K
Q2 25
$15.2M
$14.0M
Q1 25
$5.0M
$-29.8M
Q4 24
$-3.7M
$-1.8M
Q3 24
$-5.9M
$-1.6M
Q2 24
$9.4M
$814.0K
FCF Margin
ILPT
ILPT
NEO
NEO
Q1 26
Q4 25
36.9%
-3.4%
Q3 25
15.9%
0.3%
Q2 25
13.5%
7.7%
Q1 25
4.5%
-17.8%
Q4 24
-3.4%
-1.0%
Q3 24
-5.5%
-0.9%
Q2 24
8.5%
0.5%
Capex Intensity
ILPT
ILPT
NEO
NEO
Q1 26
Q4 25
16.4%
4.1%
Q3 25
4.6%
4.4%
Q2 25
2.9%
3.5%
Q1 25
5.7%
2.7%
Q4 24
5.2%
6.7%
Q3 24
2.3%
6.4%
Q2 24
1.3%
8.0%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons